Masimo Corporation (MASI) - Total Liabilities

Latest as of December 2025: $977.70 Million USD

Based on the latest financial reports, Masimo Corporation (MASI) has total liabilities worth $977.70 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Masimo Corporation growing its equity to track the company's year-over-year net asset growth rate.

Masimo Corporation - Total Liabilities Trend (1998–2025)

This chart illustrates how Masimo Corporation's total liabilities have evolved over time, based on quarterly financial data. See MASI free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Masimo Corporation Competitors by Total Liabilities

The table below lists competitors of Masimo Corporation ranked by their total liabilities.

Company Country Total Liabilities
Aecom Technology Corporation
NYSE:ACM
USA $9.49 Billion
L E Lundbergföretagen AB (publ)
ST:LUND-B
Sweden Skr60.77 Billion
Chang Hwa Commercial Bank Ltd
TW:2801
Taiwan NT$3.26 Trillion
Autoliv Inc
ST:ALIV-SDB
Sweden Skr5.86 Billion
PayPay Corporation American Depository Shares
NASDAQ:PAYP
USA $4.85 Trillion
Chart Industries Inc
NYSE:GTLS
USA $6.42 Billion
Jiangsu Yoke Technology Co Ltd
SHE:002409
China CN¥6.30 Billion
China Eastern Airlines Corp Ltd
SHG:600115
China CN¥256.87 Billion

Liability Composition Analysis (1998–2025)

This chart breaks down Masimo Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Masimo Corporation (MASI) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.49 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.36 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.58 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Masimo Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Masimo Corporation (1998–2025)

The table below shows the annual total liabilities of Masimo Corporation from 1998 to 2025.

Year Total Liabilities Change
2025-12-31 $977.70 Million -37.88%
2024-12-31 $1.57 Billion -6.14%
2023-12-31 $1.68 Billion -10.42%
2022-12-31 $1.87 Billion +455.73%
2021-12-31 $336.80 Million +10.46%
2020-12-31 $304.91 Million +33.58%
2019-12-31 $228.25 Million +22.88%
2018-12-31 $185.75 Million +2.39%
2017-12-31 $181.41 Million -30.30%
2016-12-31 $260.29 Million -20.16%
2015-12-31 $326.02 Million +26.73%
2014-12-31 $257.26 Million +129.17%
2013-12-31 $112.26 Million +13.40%
2012-12-31 $98.99 Million +14.52%
2011-12-31 $86.44 Million +7.78%
2010-12-31 $80.20 Million +20.31%
2009-12-31 $66.66 Million -9.74%
2008-12-31 $73.85 Million -13.57%
2007-12-31 $85.44 Million -16.32%
2006-12-31 $102.11 Million -49.37%
2005-12-31 $201.67 Million +29.45%
2003-12-31 $155.79 Million +17.32%
2002-12-31 $132.79 Million +2503.80%
1999-12-31 $5.10 Million +59.38%
1998-12-31 $3.20 Million --

About Masimo Corporation

NASDAQ:MASI USA Medical Devices
Market Cap
$9.42 Billion
Market Cap Rank
#2340 Global
#861 in USA
Share Price
$179.95
Change (1 day)
+0.00%
52-Week Range
$127.40 - $179.95
All Time High
$303.29
About

Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET pla… Read more